COMMUNIQUÉS West-GlobeNewswire

The Emily Program Announces Residential Treatment Expansion to Adults in Columbus, Ohio
17/01/2024
With the addition of adult residential treatment in Columbus, the eating disorder program will offer all levels of care to people of all ages and genders in Central Ohio COLUMBUS, Ohio, Jan. 17, 2024 (GLOBE NEWSWIRE [...]
Trxade health, Inc files its 3Q 10Q
17/01/2024
TAMPA, FL, Jan. 17, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, announced today that it filed its Quarterly Report [...]
Sienna Announces Fourth Quarter 2023 Results Release Date and Conference Call
17/01/2024
MARKHAM, Ontario, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2023 fourth quarter results after market close on Tuesday, [...]
NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market
17/01/2024
TORONTO and HAIFA, Israel, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “ Company ” or “ NurExone ”), a biopharmaceutical company developing biologically-guided exosome [...]
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
17/01/2024
AMPLIFY-7P study builds on preliminary positive findings from the 2-peptide formulation of ELI-002 published in Nature Medicine demonstrating tumor biomarker reduction, with strong T cell responses that correlated with [...]
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
17/01/2024
Cleared First Four Monotherapy Doses and Initial Combination Cohort with No Dose Limiting Toxicities at any Dose Level KVA12123 Monotherapy Demonstrated Dose Proportional Induction of Pro-inflammatory Biomarkers [...]
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
17/01/2024
INVO (NASDAQ: INVO ) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024 Experienced, entrepreneurial leadership team to help structure merged public company and [...]
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
17/01/2024
Second study of Allocetra in knee osteoarthritis, following the on-going Phase I/II trial in pre-surgery, end-stage osteoarthritis, that is continuing to enroll patients Nes-Ziona, Israel, Jan. 17, 2024 (GLOBE NEWSWIRE [...]
Daré Bioscience Announces Grant to Support Biotherapeutic Product Development
17/01/2024
Grant funds support activities that will aid the ultimate development of bacteria-based biotherapeutic products designed to benefit women and newborns SAN DIEGO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. ( [...]
Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region
17/01/2024
Windtree to receive potential future milestones up to $138MM plus up to low double digit royalties and full coverage for all development, manufacturing, regulatory and commercialization costs for products in the [...]
Day One Announces Two New Appointments to Board of Directors
17/01/2024
BRISBANE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted [...]
Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders
17/01/2024
Safety Shot is Not GBB Drink Lab, Inc. (GBB) and never acquired GBB as falsely claimed by FSD Pharma; Only the Safety Shot beverage asset was acquired; The lawsuit referred to by FSD Pharma is with GBB only GBB [...]
Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme
17/01/2024
BASKING RIDGE, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]
Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
17/01/2024
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it will present new data on its FDA approved allogeneic [...]
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
17/01/2024
FIT YOUR OUTFIT (FYO) the App That Scientifically Measures and Tracks Body Composition With A SINGLE PHOTO FROM YOUR SMARTPHONE LAS VEGAS, NV, Jan. 17, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. ( [...]
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution
17/01/2024
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands accessibility of Nociscan on the worldwide MR market Builds on preexisting [...]
Jack Ride 15 Brings Community Together to End the Youth Mental Health Emergency
17/01/2024
Jack.org invites you to join Canada’s Ride for Youth Mental Health and support life-changing youth mental health programs in communities across Canada TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Jack.org, a leading [...]
La Jack Ride 15 Mobilise La Communauté Pour Mettre Fin À La Crise En Santé Mentale Des Jeunes
17/01/2024
Jack.org vous invite à Rouler pour la santé mentale des jeunes et à soutenir les programmes de qui s’y rapportent; programmes porteurs de changement dans les communautés canadiennes. TORONTO, 17 janv. 2024 (GLOBE [...]
ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis
17/01/2024
Up to 40% of women with triple negative breast cancer (TNBC) experience metastasis to their brain, which affects physical function, independence, personality, quality of life, and significantly increases mortality rates [...]

Pages